Cyient Limited (CYIENT)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 revenue $174.2M, +7.5% q-q, +6.3% y-y constant currency; EBIT margin 14.2%, highest in 10 quarters
- Semiconductor revenue $19.3M, +8% q-q; EBIT loss due to R&D investments; breakeven expected FY28
- DLM revenue +26% y-y INR; order book highest ever with book-to-bill >1.6
- TAO Digital acquisition added $9.6M revenue; expected $100-110M run rate next 12 months
- Order intake $158.4M, +21% y-y; €50M framework contract ramping over 1-2 years
- Cost optimization supports margin despite wage hikes in H2FY27
- Transportation & mobility segment strong growth; defense and semiconductor are key growth areas
- Free cash flow Rs.214 Cr, 140% PAT conversion; buyback Rs.720 Cr completed
- Multiple analyst queries on Semiconductor supply constraints and margin impact; management expects supply to catch up with demand
- Net hedge covers ~50% of next 12 months at average rate 95.6; 5-year loan for TAO acquisition at SOFR plus spread
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 CYIENT — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add CYIENT to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Cyient Limited
Important.
The summary above is generated automatically from Cyient Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.